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Background
The key to managing latex allergies in healthcare professionals and patients lies in correct recognition
and appropriate action.
7.7 million people are employed in the health care sector. While there are no overall statistics on the
prevalence of latex allergy in that work force, studies do indicate that 8 to 12% of health care workers
regularly exposed are sensitized, compared with 1 to 6% of the general population.
Latex allergy is defined as an immune mediated reaction to latex products (e.g. balloons, contact
dermatitis for gloves, condoms, surgical catheters); these encompass immediate and delayed
hypersensitivity reactions.
 
Method
Based on the experience of the Belgian Dutch Pathway Network, a 7-phase method to develop,
implement, evaluate and continuously follow up a care pathway for latex allegy was designed and
implemented.
The purpose of the study was to develop and implementation of latex allergy clinical care pathways
to provide all staff at Ghent university Hospital with appropriate knowledge and skills to identify and
manage patients who have a known latex allergy or those at risk of developing latex allergy
Results
 
Care pathways, also known as clinical pathways, are used all over the world to implement and monitor
patient-centered care processes in a transparent way. Care pathways are defined as a complex
intervention.7 -phase method consists of: 1) screening phase; 2) project management phase; 3)
diagnostic- and objectification phase; 4) development phase; 5) implementation phase; 6) evaluation
phase and 7) continuous follow-up phase. This phased approach is based on the Deming cycle, better
known as the "plan-do-study-act" (PDSA)-cycle
 
Conclusion
This method can offer support to multidisciplinary teams (re)designing and implementing safe,
efficient, effective, person-centered, timely, equitable, continuous and integrated care processes.
However, the method is no guarantee to success. The key to success is the collaboration and critical
attitude of the entire multidisciplinary team when implementing pathways.
The objective of the development of care pathways is to optimise patient and health care professionals’
safety and to improve health care quality.
 
